// STATE LEGISLATION TRACKER

Missouri HB 2744 — Requires instruction on human growth and development in schools

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Missouri
Bill: HB 2744
Filed: 2026-01-06
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Missouri HB2744 appears to deal with school instruction on human growth and development. Based only on the title and subjects provided, it does not appear to affect compounded peptides, prescribing, telehealth, clinician scope, FDA compounding rules, controlled substances, or prescription monitoring.

Key Points

No apparent change to peptide prescribing or access
No apparent effect on compounded peptide pharmacies
No apparent telehealth or clinician-scope changes

What to Watch For

Note If bill text becomes available, confirm it stays limited to school curriculum.

Note No peptide-related impact can be identified from the title and subjects alone.

Where the Bill Stands

The available status says the OpenStates refetch failed, so the bill's current position in the process is unknown.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws